TR201010212A2 - Solid oral dosage form containing cefdinir. - Google Patents

Solid oral dosage form containing cefdinir.

Info

Publication number
TR201010212A2
TR201010212A2 TR2010/10212A TR201010212A TR201010212A2 TR 201010212 A2 TR201010212 A2 TR 201010212A2 TR 2010/10212 A TR2010/10212 A TR 2010/10212A TR 201010212 A TR201010212 A TR 201010212A TR 201010212 A2 TR201010212 A2 TR 201010212A2
Authority
TR
Turkey
Prior art keywords
dosage form
oral dosage
solid oral
form containing
containing cefdinir
Prior art date
Application number
TR2010/10212A
Other languages
Turkish (tr)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2010/10212A priority Critical patent/TR201010212A2/en
Priority to PCT/TR2011/000273 priority patent/WO2012078121A2/en
Publication of TR201010212A2 publication Critical patent/TR201010212A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

Mevcut buluş, aktif ajan olarak sefdinir içeren farmasötik bileşimlere ve bu bileşimlerin hazırlanmasında kullanılacak bir üretim yöntemine ilişkindir.The present invention relates to pharmaceutical compositions containing cefdinir as active agent and a production method to be used in the preparation of these compositions.

TR2010/10212A 2010-12-08 2010-12-08 Solid oral dosage form containing cefdinir. TR201010212A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2010/10212A TR201010212A2 (en) 2010-12-08 2010-12-08 Solid oral dosage form containing cefdinir.
PCT/TR2011/000273 WO2012078121A2 (en) 2010-12-08 2011-12-02 Solid oral dosage form comprising cefdinir

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2010/10212A TR201010212A2 (en) 2010-12-08 2010-12-08 Solid oral dosage form containing cefdinir.

Publications (1)

Publication Number Publication Date
TR201010212A2 true TR201010212A2 (en) 2012-06-21

Family

ID=45491749

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2010/10212A TR201010212A2 (en) 2010-12-08 2010-12-08 Solid oral dosage form containing cefdinir.

Country Status (2)

Country Link
TR (1) TR201010212A2 (en)
WO (1) WO2012078121A2 (en)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA836918B (en) 1982-09-30 1984-05-30 Fujisawa Pharmaceutical Co 7-substituted-3-vinyl-3-cephem compounds and processes for the production of the same
ES2173420T3 (en) * 1996-02-29 2002-10-16 Fujisawa Pharmaceutical Co TABLETS CONTAINING AN ANTIBIOTIC BETA-LACTAMIC AND PROCEDURE FOR PRODUCTION.
US20050131079A1 (en) * 2003-12-10 2005-06-16 Pujara Chetan P. Cefdinir oral suspension
US20050245738A1 (en) * 2004-05-03 2005-11-03 Lupin Ltd Stable bioavailable crystalline form or cefdinir and a process for the preparation thereof
JP2007077123A (en) * 2005-09-16 2007-03-29 Shiono Chemical Co Ltd Amorphous cefdinir, method for producing the same and oral administration pharmaceutical composition containing the same
CN101002745A (en) * 2005-09-26 2007-07-25 刘凤鸣 Slow release preparation of cefdinir
US20070128268A1 (en) * 2005-12-07 2007-06-07 Herwig Jennewein Pharmaceutical compositions comprising an antibiotic
WO2007086078A2 (en) * 2006-01-30 2007-08-02 Panacea Biotec Ltd. Novel pharmaceutical compositions and process of preparation thereof
EP2015755A4 (en) * 2006-04-28 2010-02-24 Wockhardt Ltd Improvements in therapy for treating resistant bacterial infections
KR100990223B1 (en) * 2008-02-21 2010-10-29 주식회사 중외제약 Pharmaceutical composition for improving dissolution rate of cefdinir
CN101352424A (en) * 2008-09-16 2009-01-28 天津市中央药业有限公司 Cefdinir dispersible tablet and preparation method thereof
TR200909787A2 (en) * 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Pharmaceutical formulations containing a third generation cephalosporin and clavulanic acid.
TR200909785A1 (en) * 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Pharmaceutical compositions containing cefdinir as the active agent.
TR201001417A1 (en) * 2010-02-25 2011-09-21 Sanovel İlaç San. Ve Ti̇c. A. Ş. Cefdinir formulation with improved dissolution rate
CN101862307A (en) * 2010-03-19 2010-10-20 杭州奥默医药技术有限公司 Bisulfate Cefdinir sodium capsule and preparation method thereof
WO2011139252A2 (en) * 2010-05-04 2011-11-10 Mahmut Bilgic Efervescent formulations comprising cefdinir

Also Published As

Publication number Publication date
WO2012078121A3 (en) 2012-08-23
WO2012078121A2 (en) 2012-06-14

Similar Documents

Publication Publication Date Title
PH12015501439A1 (en) Oral care products comprising zinc oxide and trimethylglycine
EA201270741A1 (en) ORAL COMPOSITIONS AND LIPOPHYL SALTS OF METHylNALTREX
GB201106743D0 (en) Novel compounds
MX2013001677A (en) Stable formulations of linaclotide.
MX2019012939A (en) Linaclotide-containing formulations for oral administration.
EA201590491A1 (en) IMMUNOGENIC COMPOSITION
EA201291211A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING HYDROMORPHONE AND NALOXONE
MX340983B (en) Pharmaceutical and nutraceutical compositions of abscisic acid.
EA201201109A1 (en) ELECTRIC WOOD IN THIN-CUT CRYSTALLINE FORM AND PHARMACEUTICAL COMPOSITION CONTAINING
TR201906685T4 (en) Pharmaceutical composition containing crystalline macitentane.
TR201009167A2 (en) Pharmaceutical granules containing cephalosporin.
MY163476A (en) Oral care compositions
EA201390950A1 (en) HOMOGENEOUS PHARMACEUTICAL ORAL DOSAGE FORMS CONTAINING LERKANIDIPIN AND ENALAPRIL OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS TOGETHER WITH ORGANIC ACID
TR200909785A1 (en) Pharmaceutical compositions containing cefdinir as the active agent.
PH12015501251A1 (en) Compositions and methods for treating dental caries
EA201500313A1 (en) STABILIZED AMORPHOUS FORM OF AGOMELATIN, THE WAY OF ITS MANUFACTURE AND PHARMACEUTICAL COMPOSITIONS, ITS CONTAINING
TR201005327A2 (en) Synergistic pharmaceutical formulations.
TR201010859A2 (en) Tablet forms containing cefdinir.
TR200906506A2 (en) Solid dosage forms containing telmisartan.
TR201009166A2 (en) Production method for cefdinir-containing pharmaceutical composition
TR201010212A2 (en) Solid oral dosage form containing cefdinir.
TR201100152A2 (en) Effervescent compositions containing amlodipine.
TR201109160A2 (en) New pharmaceutical compositions containing eplerenone.
TR201009165A2 (en) Tablets containing cefdinir
TR201009399A2 (en) Rapidly soluble effervescent rosuvastatin formulations.